Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Daito Pharmaceutical Co., Ltd. ( (JP:4577) ) has issued an announcement.
Daito Pharmaceutical Co., Ltd. announced the repurchase of 134,000 of its own shares, amounting to 163,958,000 yen, as part of a broader plan to buy back up to 1,000,000 shares by May 2026. This strategic move is likely aimed at enhancing shareholder value and optimizing the company’s capital structure.
The most recent analyst rating on (JP:4577) stock is a Hold with a Yen1261.00 price target. To see the full list of analyst forecasts on Daito Pharmaceutical Co., Ltd. stock, see the JP:4577 Stock Forecast page.
More about Daito Pharmaceutical Co., Ltd.
Daito Pharmaceutical Co., Ltd. operates in the pharmaceutical industry, focusing on the development and distribution of pharmaceutical products. The company is listed on the Prime Market of the Tokyo Stock Exchange.
Average Trading Volume: 59,021
Technical Sentiment Signal: Buy
Current Market Cap: Yen37.43B
For detailed information about 4577 stock, go to TipRanks’ Stock Analysis page.